195 related articles for article (PubMed ID: 23124107)
1. Aqueous solubility: simple predictive methods (in silico, in vitro and bio-relevant approaches).
Elder D; Holm R
Int J Pharm; 2013 Aug; 453(1):3-11. PubMed ID: 23124107
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systems.
Crivori P; Morelli A; Pezzetta D; Rocchetti M; Poggesi I
Eur J Pharm Sci; 2007 Nov; 32(3):169-81. PubMed ID: 17714921
[TBL] [Abstract][Full Text] [Related]
3. Aqueous solubility of crystalline and amorphous drugs: Challenges in measurement.
Murdande SB; Pikal MJ; Shanker RM; Bogner RH
Pharm Dev Technol; 2011 Jun; 16(3):187-200. PubMed ID: 20429826
[TBL] [Abstract][Full Text] [Related]
4. In silico prediction of drug solubility in water-dioxane mixtures using the Jouyban-Acree model.
Jouyban A
Pharmazie; 2007 Jan; 62(1):46-50. PubMed ID: 17294813
[TBL] [Abstract][Full Text] [Related]
5. In silico prediction of aqueous solubility: a multimodel protocol based on chemical similarity.
Chevillard F; Lagorce D; Reynès C; Villoutreix BO; Vayer P; Miteva MA
Mol Pharm; 2012 Nov; 9(11):3127-35. PubMed ID: 23072744
[TBL] [Abstract][Full Text] [Related]
6. Computational approaches to determine drug solubility.
Faller B; Ertl P
Adv Drug Deliv Rev; 2007 Jul; 59(7):533-45. PubMed ID: 17588703
[TBL] [Abstract][Full Text] [Related]
7. In silico prediction of aqueous solubility: the solubility challenge.
Hewitt M; Cronin MT; Enoch SJ; Madden JC; Roberts DW; Dearden JC
J Chem Inf Model; 2009 Nov; 49(11):2572-87. PubMed ID: 19877720
[TBL] [Abstract][Full Text] [Related]
8. Methodology for phase selection of a weak basic drug candidate, utilizing kinetic solubility profiles in bio-relevant media.
Furukawa S; Zhao C; Ohki Y
Eur J Pharm Biopharm; 2010 Feb; 74(2):298-303. PubMed ID: 19815062
[TBL] [Abstract][Full Text] [Related]
9. Predicting aqueous solubility from structure.
Delaney JS
Drug Discov Today; 2005 Feb; 10(4):289-95. PubMed ID: 15708748
[TBL] [Abstract][Full Text] [Related]
10. Predictive models for oral drug absorption: from in silico methods to integrated dynamical models.
Dokoumetzidis A; Kalantzi L; Fotaki N
Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):491-505. PubMed ID: 17696801
[TBL] [Abstract][Full Text] [Related]
11. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study.
Kuentz M; Nick S; Parrott N; Röthlisberger D
Eur J Pharm Sci; 2006 Jan; 27(1):91-9. PubMed ID: 16219449
[TBL] [Abstract][Full Text] [Related]
12. Low solubility in drug development: de-convoluting the relative importance of solvation and crystal packing.
Docherty R; Pencheva K; Abramov YA
J Pharm Pharmacol; 2015 Jun; 67(6):847-56. PubMed ID: 25880016
[TBL] [Abstract][Full Text] [Related]
13. Global and local computational models for aqueous solubility prediction of drug-like molecules.
Bergström CA; Wassvik CM; Norinder U; Luthman K; Artursson P
J Chem Inf Comput Sci; 2004; 44(4):1477-88. PubMed ID: 15272856
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in intravenous delivery of poorly water-soluble compounds.
Shi Y; Porter W; Merdan T; Li LC
Expert Opin Drug Deliv; 2009 Dec; 6(12):1261-82. PubMed ID: 19941409
[TBL] [Abstract][Full Text] [Related]
15. Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity.
Hill AP; Young RJ
Drug Discov Today; 2010 Aug; 15(15-16):648-55. PubMed ID: 20570751
[TBL] [Abstract][Full Text] [Related]
16. In silico approaches to prediction of aqueous and DMSO solubility of drug-like compounds: trends, problems and solutions.
Balakin KV; Savchuk NP; Tetko IV
Curr Med Chem; 2006; 13(2):223-41. PubMed ID: 16472214
[TBL] [Abstract][Full Text] [Related]
17. Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations.
O'Driscoll CM; Griffin BT
Adv Drug Deliv Rev; 2008 Mar; 60(6):617-24. PubMed ID: 18155800
[TBL] [Abstract][Full Text] [Related]
18. Advanced screening assays to rapidly identify solubility-enhancing formulations: high-throughput, miniaturization and automation.
Dai WG; Pollock-Dove C; Dong LC; Li S
Adv Drug Deliv Rev; 2008 Mar; 60(6):657-72. PubMed ID: 18222563
[TBL] [Abstract][Full Text] [Related]
19. Computational aqueous solubility prediction for drug-like compounds in congeneric series.
Du-Cuny L; Huwyler J; Wiese M; Kansy M
Eur J Med Chem; 2008 Mar; 43(3):501-12. PubMed ID: 17574307
[TBL] [Abstract][Full Text] [Related]
20. Overcoming sink limitations in dissolution testing: a review of traditional methods and the potential utility of biphasic systems.
Phillips DJ; Pygall SR; Cooper VB; Mann JC
J Pharm Pharmacol; 2012 Nov; 64(11):1549-59. PubMed ID: 23058042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
